Dr. Reddy’s Laboratories Launched New Capsule Approved By USFDA

Hyderabad, sept.26 (Hydnow): Dr. Reddy’s Laboratories Ltd. today announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera® (dimethyl fumarate) Delayed-Release Capsules, approved by the U.S. Food and Drug Administration (USFDA).

The Tecfidera® brand and generic market had U.S. sales of approximately $3.8 billion MAT for the most recent twelve months ending in June 2020 according to IQVIA Health*.

Dr. Reddy’s Dimethyl Fumarate Delayed-Release Capsules are available in 120 mg and 240 mg capsules in bottle count sizes of 14 and 60 capsules, respectively.(Hydnow)

Leave a Reply

Your email address will not be published. Required fields are marked *